Citations

Showing 10 of 108152 citations.

SAFETY AND EFFICACY OF THE PD‐L1 INHIBITOR DURVALUMAB WITH R‐CHOP OR R2‐CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH‐RISK DLBCL
Nowakowski, Grzegorz S. , Willenbacher, Wolfgang , Greil, Richard , Larsen, Thomas Stauffer , Manges, Robert, Trümper, Lorenz, Everaus, Hele, Kalakonda, Nagesh , Knoble, Jeanna, Jørgensen, Judit , Rubio, Neus Domper, Casadebaig, Marie‐Laure, Manzke, Oliver, Cunningham, David , Patel, Krish , Jäger, Ulrich , Haïoun, Corinne , Brown, Peter de Nully , Cunningham, David , Muñoz, Javier

Mayo Clinic

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 132-134

10.1002/hon.93_2629 Get It

PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II‐IV PERIPHERAL T‐CELL LYMPHOMA: PHASE II RESULTS
Lunning, Matthew A. , Lee, H., Mehta–Shah, Neha , Haverkos, Bradley M. , Lechowicz, MaryJo, Moskowitz, Alison J. , Heires, Peggy, Lyden, Liz, Ansell, Stephen M. , Horwitz, Steven M. , Advani, Ranjana H. , Vose, Julie M. , Lee, H., Zain, Jasmine

Mayo Clinic

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 280-281

10.1002/hon.91_2630 Get It

PRE‐TREATMENT HEMOGLOBIN AND OUTCOME IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH ANTHRACYCLINE CONTAINING CHEMOTHERAPY
Ulrichsen, Sinna Pilgaard , Larsen, Thomas Stauffer , Himmelstrup, Bodil , Rønnov-Jessen, Dorte, Nowakowski, Grzegorz S. , Thompson, Carrie A. , Madsen, J. , Pedersen, Robert Schou, Gørløv, Jette Sønderskov, d’Amore, Francesco, Clausen, Michael Roost , Maurer, Matthew J. , Link, Brian K. , Feldman, Andrew L. , Slager, Susan L. , Pedersen, Per Trøllund , Cerhan, James R.

Mayo Clinic

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 418-420

10.1002/hon.88_2631 Get It

EXTENDED FOLLOW‐UP OF A PHASE I TRIAL OF IPILIMUMAB, NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN RELAPSED HODGKIN LYMPHOMA: A TRIAL OF THE ECOG‐ACRIN RESEARCH GROUP (E4412)
Cohen, Jonathon B. , Robertson, May C., David, Kevin A. , Fenske, Timothy S. , Palmisano, N., Svoboda, Jakub , Morgan, D. , Ansell, Stephen M. , Diefenbach, Catherine , Hong, Fangxin , Ambinder, Richard F. , Robertson, M., Advani, Ranjana H. , Barta, Stefan K , Morgan, D., Karmali, Reem , Kahl, Brad S.

Mayo Clinic

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 123-124

10.1002/hon.83_2629 Get It

CLINICAL FEATURES, TREATMENT AND OUTCOME OF NEUROLYMPHOMATOSIS: SINGLE INSTITUTION EXPERIENCE
Nowakowski, Grzegorz S. , Micallef, Ivana N. , Ristow, Kay M., Johnston, Patrick B. , Novo, Mattia , Habermann, Thomas M.

Mayo Clinic

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 269-271

10.1002/hon.80_2630 Get It

AUGMENT PHASE III STUDY: LENALIDOMIDE/RITUXIMAB (R2) IMPROVED EFFICACY OVER RITUXIMAB/PLACEBO IN RELAPSED/REFRACTORY FOLLICULAR PATIENTS IRRESPECTIVE OF POD24 STATUS
Leonard, John P. , Fowler, Nathan , Zhang, H., Offner, Fritz , Scheliga, Adriana , Nowakowski, Grzegorz S. , Fogliatto, Laura Maria , Moreira, C. , Czuczman, M. S., Kalambakas, Stacey, Wu, Chengqing , Gribben, JG, Trněný, Marek , Izutsu, Koji , Hong, X., Pinto, Antonio , Re, F., Scheinberg, Phillip , Flinn, Ian W. , Fustier, Pierre

Mayo Clinic

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 114-115

10.1002/hon.75_2629 Get It

ADDITION OF LENALIDOMIDE TO R‐CHOP (R2CHOP) IMPROVES OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): FIRST REPORT OF ECOG‐ACRIN1412 A RANDOMIZED PHASE 2 US INTERGROUP STUDY OF R2CHOP VS R‐CHOP
Nowakowski, Grzegorz S. , Macon, Rita E., King, Rebecca L. , Wagner‐Johnston, Nina, Wade, James L. , Nagargoje, Gauri G., Reynolds, Christopher M. , Cohen, Jonathon B. , Amengual, Jennifer E. , Richards, Kristy L. , Little, Richard F. , Leonard, John P. , Friedberg, Jonathan W. , Kostakoglu, Lale , Kahl, Bradley, Hong, Fangxin , Scott, David W. , Habermann, Thomas M. , Casulo, Carla , Khan, Niloufer , Witzig, Thomas E.

Mayo Clinic

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 37-38

10.1002/hon.6_2629 Get It

PET‐CR AS A SURROGATE FOR SURVIVAL OUTCOMES IN DLBCL: A LITERATURE BASED META‐ANALYSIS
Berry, Donald A. , Şahin, Deniz , Nielsen, Tina, Mattiello, F., Foster, M. E., Nowakowski, Grzegorz S. , Kostakoğlu, Lale , Broglio, Kristine , Ward, Chris , McGlothlin, Anna , Wendelberger, Barbara , Foster, M.

Mayo Clinic

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 250-251

10.1002/hon.59_2630 Get It

CLINICAL ACTIVITY OF REGN1979, AN ANTI‐CD20 X ANTI‐CD3 BISPECIFIC ANTIBODY (AB) IN PATIENTS (PTS) WITH (W/) RELAPSED/REFRACTORY (R/R) B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL)
Topp, Max S. , Arnason, Jon , Brown, Jennifer R. , Allan, John N. , Ansell, Stephen M. , Duell, Johannes , Rosenwald, Andreas , Charnas, Robert L., Ambati, Srikanth, Adriaens, Lieve, Ufkin, Melanie, Li, J. , Gasparini, Peter, Janković, Vladimir , Fiaschi, Nathalie , Zhang, W., Hamon, Sara , Yancopoulos, George D., Lowy, Israel , Sternberg, David , Advani, Ranjana H. , O’Brien, Susan , Chavez, Julio C , Zhu, Min , Thurston, Gavin , Murphy, Andrew James , Bannerji, Rajat

Mayo Clinic

Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 90-92

10.1002/hon.58_2629 Get It